Dyne Therapeutics, Inc. - DYN

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$3.63B
QoQ value delta ($000)
+$423.7M (+13.22%)
Implied price effect (QoQ)
-6.99%
Shares
Total shares
199,497,077
QoQ shares delta
+35,610,079 (+21.73%)
Total shares held by funds (by quarter)

Market chart (DYN)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 227 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
T. Rowe Price Investment Management, Inc. 558,147 30,785,801 0.38%
JANUS HENDERSON GROUP PLC 247,426 13,647,376 0.12%
VANGUARD GROUP INC 219,376 11,215,565 0.0%
BlackRock, Inc. 212,118 11,699,870 0.0%
Atlas Venture Life Science Advisors, LLC 165,535 9,130,465 20.95%
FMR LLC 161,519 8,908,980 0.01%
Orbis Allan Gray Ltd 122,599 6,762,231 0.52%
STATE STREET CORP 120,632 6,653,746 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 116,123 6,405,069 0.0%
PERCEPTIVE ADVISORS LLC 84,646 4,668,839 1.66%
FCPM III SERVICES B.V. 84,202 4,644,386 11.66%
TCG Crossover Management, LLC 83,672 4,615,144 2.39%
VANGUARD PORTFOLIO MANAGEMENT LLC 75,457 4,162,041 0.0%
Vestal Point Capital, LP 72,520 4,000,000 2.03%
GEODE CAPITAL MANAGEMENT, LLC 63,542 3,504,114 0.0%
ARMISTICE CAPITAL, LLC 57,564 3,175,110 1.02%
Frazier Life Sciences Management, L.P. 57,165 3,153,082 1.47%
JPMORGAN CHASE & CO 55,601 3,253,473 0.0%
ORBIMED ADVISORS LLC 52,901 2,917,884 1.05%
PRICE T ROWE ASSOCIATES INC /MD/ 42,215 2,328,373 0.0%
Siren, L.L.C. 40,414 2,229,125 1.12%
Venrock Adviser, LLC 39,413 2,173,913 1.47%
FRANKLIN RESOURCES INC 36,424 2,009,082 0.01%
Deep Track Capital, LP 36,260 2,000,000 0.59%
SAMLYN CAPITAL, LLC 34,855 1,922,543 0.59%